21 hours Agios Pharmaceuticals: Liver Toxicity Issues May Threaten Thalassemia Approval (Rating Downgrade) Seeking Alpha X
1 day Vertex Pharmaceuticals Gets a Huge FDA Approval Which Could Send the Stock Skyrocketing Yahoo Finance X
2 days Kiniksa Pharmaceuticals: Strong Improvement In Arcalyst Revenue, But Risks Remain Seeking Alpha X
2 days Acadia Pharmaceuticals: Good Progress Means I’m Reversing My ‘Sell’ Call To ‘Buy’ Seeking Alpha X
3 days Inovio Pharmaceuticals Inc (INO) Oppenheimer 35th Annual Healthcare Life Sciences Conference (Transcript) Seeking Alpha X
5 days Vertex Pharmaceuticals Incorporated 2024 Q4 – Results – Earnings Call Presentation Seeking Alpha X
5 days Cautious On Arrowhead Pharmaceuticals’ FDA NDA Acceptance Due To Valuation Concerns Seeking Alpha X
1 week Alnylam Pharmaceuticals (ALNY) May Report Negative Earnings: Know the Trend Ahead of Next Week’s Release Zacks X
1 week ARS Pharmaceuticals’ Neffy Launch Could Be A Hit For Severe Allergic Reactions Seeking Alpha X
1 week Unlocking Q4 Potential of Vertex (VRTX): Exploring Wall Street Estimates for Key Metrics Zacks X
2 weeks Regeneron Pharmaceuticals Beats On Libtayo’s Back, Unveils Dividend Investor's Business Daily X
2 weeks Regeneron’s earnings boosted by more than doubling of U.S. sales of blockbuster eye drug Eylea MarketWatch X
2 weeks Wall Street Analysts Predict a 27.12% Upside in Amneal (AMRX): Here’s What You Should Know Zacks X
2 weeks Zentalis Pharmaceuticals (ZNTL) Loses -46.3% in 4 Weeks, Here’s Why a Trend Reversal May be Around the Corner Zacks X